CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

SOPHiA GENETICS Reports Second Quarter 2026 Results

EarningsNeutral
AI Analysis

Summary

SOPHiA GENETICS reported second quarter 2026 financial results with revenue of $23.3 million. The company is an AI-driven precision medicine leader listed on Nasdaq.

Financial Highlights

Revenue

$23.3 million

Importance:2/10
Sentiment:
0.00
earningsQ2 2026financial resultsAI-driven precision medicine
Related Companies

Read the original article

Published by PR Newswire Pharma on August 4, 2026 10:45 AM

Read Original